Clinical trials for the prevention and treatment of COVID ‐19: current state of play
Author:
Affiliation:
1. Menzies School of Health Research Darwin NT
2. John Hunter Hospital Newcastle NSW
3. Royal Melbourne Hospital Melbourne VIC
4. University of Melbourne Melbourne VIC
5. Peter Doherty Institute for Infection and Immunity Melbourne VIC
Publisher
AMPCo
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.50673
Reference19 articles.
1. Outbreak of severe acute respiratory syndrome–worldwide, 2003;US Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2003
2. Patient with new strain of coronavirus is treated in intensive care at London hospital
3. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
4. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
5. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The relationship between trust in federal oversight of vaccine safety and willingness to participate in COVID-19 clinical trials: a repeated measures study of Philadelphia residents (September 2021 – March 2023);BMC Public Health;2024-07-31
2. The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review;Frontiers in Pharmacology;2024-05-30
3. Role of Nurses in the Management of Cardiopulmonary Complication, Assessment, and Management in COVID-19 Patients Nursing Care;Nursing Practice during COVID-19: Preparation, Education and Support;2024
4. Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis;Cochrane Database of Systematic Reviews;2023-09-01
5. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers;Clinical Microbiology and Infection;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3